Neuropeutics is collaborating with LifeArc on a small molecule therapy that reportedly lowered TDP-43 clumping in an animal ...

In a real-world study, In the end, researchers compared 395 ALS patients who'd been given Radicava against 395 matched ...

Ncardia’s iPSC-derived microglia may aid ALS research and help to screen new therapies that target inflammation in ALS.

Columnist Dagmar Munn turns to affirmations and positive self-talk on those occasional days when she feels shut down.

Masitinib is an oral inhibitor of tyrosine kinases, enzymes important for immune cells thought to drive ALS inflammation and ...

The genes included those involved in the function of energy-producing mitochondria, lipid and iron metabolism, and the ...

ALS is a disease of continual losses and trade-offs. We walk a tightrope between safety and independence, and caution and quality of life.